Related Experiment Video
Updated: Jun 14, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline
Wei Sha1, Kerry-Ann da Costa, Leslie M Fischer
1Bioinformatics Research Center, University of North Carolina at Charlotte, USA.
Plasma metabolomic profiles can predict liver dysfunction risk from choline deficiency. This finding aids in identifying individuals susceptible to organ damage due to inadequate choline intake.
Area of Science:
- Nutritional biochemistry
- Metabolomics
- Human physiology
Background:
- Choline is an essential nutrient vital for liver and muscle function.
- Genetic variations can influence susceptibility to choline deficiency-induced organ dysfunction.
- Metabolic inefficiencies may underlie this altered risk.
Purpose of the Study:
- To determine if baseline plasma metabolomic profiling can predict the development of liver dysfunction upon choline deprivation.
- To investigate the relationship between baseline metabolic profiles and choline deficiency-induced organ dysfunction.
Main Methods:
- Fifty-three participants underwent a controlled choline depletion diet.
- Plasma samples were collected at baseline, during depletion, and after repletion.
- Targeted and nontargeted metabolomic profiling was performed on plasma.
- Liver fat accumulation was assessed using magnetic resonance spectroscopy.
Main Results:
- Metabolomic profiling correlated highly with targeted biochemical analyses.
- Choline depletion led to detectable changes in plasma small molecule concentrations.
- Baseline metabolomic profiles accurately predicted which participants would develop liver dysfunction.
Conclusions:
- Plasma metabolomic profiles obtained during a choline-adequate diet can predict susceptibility to choline deficiency-induced liver dysfunction.
- Metabolomic profiling offers a potential tool for identifying at-risk individuals.
- Understanding metabolic variations is key to predicting organ dysfunction risk.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

